PCNTinactive

Point of Care Nano-Technology, Inc.

Healthcare·Healthcare·Commercial
5.4/10

BioSniper Score

Based on 4 of 6 signals

Market Cap

—

Cash Runway

3.4 mo

Lead Asset

axs-1 lite wheelchair

Next Catalyst

—

Tracking 31 pipeline candidates for Point of Care Nano-Technology, Inc. · Updated within the last hour.

Go deeper on Point of Care Nano-Technology, Inc. with Spotter

Ask follow-up questions and run a full multi-agent deep dive on PCNT — live, with citations.

Ask Spotter

Score breakdownBased on 4 of 6 signals · derived from public data

Cash Runway0.9

3.4 months

Financial Health0.5

OCF -$261 · Net income -$5K

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth10.0

31 candidates

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider SignalN/A

No insider transactions in the last 180 days

Key Financialsas of April 30, 2024

Cash

$12

Quarterly Burn

$261

Free Cash Flow

-$261

Total Liabilities

$146K

Shareholders Equity

-$35K

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Oct 2026
Today~7 mo out
Catalyst within runway

Pipeline (31 candidates)

DrugPhase
axs-1 lite wheelchair—
breathkey model g10—
deluxe nebulizer—
elegant blue—
elegant nitrile powder free examination glove blue violet—
evacore fully disposable vacuum assist biopsy device—
ez salivaApproved
i-stat 1 wireless analyzer—
i-stat alinity system with i-stat glucose test—
i-stat alinity system with i-stat sodium test—

Showing 10 of 31 candidates. Sign up for full pipeline.

Commercialization & Governance

Commercialization

Status
Commercial
Has Revenue
Yes

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.

Get the full picture on Point of Care Nano-Technology, Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar